About Biocerna
Biocerna is a company based in United States founded in 2012 by Christopher Sanders was acquired by Matrix Medical Network in October 2020. The company has 14 employees as of December 31, 2022. Biocerna operates in a competitive market with competitors including Guardant Health, Foundation Medicine, ArcherDX, Natera and Strand Life Sciences, among others.
- Headquarter Howard County, United States
- Employees 14 as on 31 Dec, 2022
- Founders Christopher Sanders
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Biocerna Llc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
14
as on Dec 31, 2022
-
Acquired by
Matrix Medical Network
(Oct 02, 2020)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Biocerna
Detailed funding history for Biocerna
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Biocerna
Biocerna has secured backing from 1 investor. Prominent investors backing the company include Matrix Medical Network.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Data analytics and managed services are provided for healthcare sectors.
|
Locked | Locked | Locked |
Investor details for Biocerna
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Biocerna
Investment portfolio details for Biocerna
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Biocerna
Detailed financials for Biocerna
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Biocerna Comparisons
Peer comparison for Biocerna
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Biocerna
Biocerna operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, Foundation Medicine, ArcherDX, Natera and Strand Life Sciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Digital sequencing technology for cancer detection is developed.
|
|
| Locked | Locked | Locked |
Genomics-based diagnostic tests for cancer are provided.
|
|
| Locked | Locked | Locked |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| Locked | Locked | Locked |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
|
| Locked | Locked | Locked |
Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery
|
|
| Locked | Locked | Locked |
Health risks are identified through online genetic and diagnostic testing.
|
Detailed competitors of Biocerna
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Biocerna
Complete news archive for Biocerna
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Biocerna
Biocerna was founded in 2012.
Biocerna is headquartered in United States. It is registered at Maryland, United States.
Christopher Sanders is the current CEO of Biocerna. They have also founded this company.
As of Dec 31, 2022, the latest employee count at Biocerna is 14.
Biocerna was founded in 2012 in Howard County, United States, within the biotechnology sector. A non-invasive diagnostics platform based on quantitative real-time PCR technology is developed for detecting major and minor BCR-ABL gene translocations. Operations focus on monitoring chronic myeloid leukemia through products such as the QuantideX qPCR BCR-ABL IS kit for p210 translocations and the QuantideX qPCR BCR-ABL minor kit for e1a2 fusion transcripts.
Biocerna's top competitors include Guardant Health, Strand Life Sciences and Foundation Medicine.
Biocerna has 1 investor. Key investors include Matrix Medical Network.